Profil
Dr. Konstantinos Karatzas is a Chief Executive Officer & Director at Acesis Holdings Corp.
He is on the Board of Directors at Acesis Holdings Corp.
and Applied Biotech Intelligence.
Dr. Karatzas was previously employed as a Chief Executive Officer by Acesis, Inc. He received his undergraduate degree from National & Kapodistrian University of Athens, a graduate degree from McGill University and an MBA from McGill University.
Aktive Positionen von Konstantinos Karatzas
| Unternehmen | Position | Beginn |
|---|---|---|
Acesis Holdings Corp.
Acesis Holdings Corp. BiotechnologyHealth Technology Functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders | Gründer | 03.10.2022 |
Applied Biotech Intelligence | Direktor/Vorstandsmitglied | 01.01.2015 |
Ehemalige bekannte Positionen von Konstantinos Karatzas
| Unternehmen | Position | Ende |
|---|---|---|
Acesis, Inc.
Acesis, Inc. Packaged SoftwareTechnology Services Develops software solutions that offers data capture forms for physicians | Vorstandsvorsitzender | - |
Ausbildung von Konstantinos Karatzas
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Acesis, Inc.
Acesis, Inc. Packaged SoftwareTechnology Services Develops software solutions that offers data capture forms for physicians | Technology Services |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National & Kapodistrian University of Athens
National & Kapodistrian University of Athens Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acesis Holdings Corp.
Acesis Holdings Corp. BiotechnologyHealth Technology Functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders | Health Technology |
Applied Biotech Intelligence |
















